Back to Journals » OncoTargets and Therapy » Volume 14

RETRACTED ARTICLE: LncRNA WT1-AS/miR-494-3p Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer
Authors Wu C, Yang J, Li R, Lin X, Wu J, Wu J
Received 21 August 2020
Accepted for publication 4 December 2020
Published 9 February 2021 Volume 2021:14 Pages 891—904
DOI https://doi.org/10.2147/OTT.S278233
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
Editor who approved publication: Prof. Dr. Takuya Aoki
This paper has been retracted.
Wu C, Yang J, Li R, Lin X, Wu J, Wu J. OncoTargets and Therapy 2021;14:891–904
We, the Editor and Publisher of the journal OncoTargets and Therapy have retracted the published article.
Following publication, concerns were raised regarding the duplication of images from Figure 3C with images from an unrelated article. Specifically,
- Images for Figure 3C, NCI-H1975, OverExp-NC, have been duplicated with images for Figure 2f, Control, from Zhu, D., Shi, C., Jiang, Y., Zhu, K., Wang, X., & Feng, W. (2021). Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21. Bioengineered, 12(1), 1505–1516. https://doi.org/10.1080/21655979.2021.1916271.
The corresponding author did not respond to our queries and was unable to provide a satisfactory explanation for how the images came to be duplicated or provide satisfactory original data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, the Publisher and Editor requested to retract the article and the corresponding author was notified of this decision.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.